SSMXY Sysmex Corporation

$11.98

Sysmex Corporation (SSMXY) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $0.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +11.4% since its last earnings release on August 7, 2026.

Sysmex Beat Consensus Estimates
Friday, August 7, 2026 · 12:00 AM ET
Earnings Date
2nd Quarter, Sep 2026
Nov 6
Friday · Before Open
Earnings Whisper
-
vs $0.11
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $12.00

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sysmex Corporation

Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan.

Sector

Healthcare

Industry

Medical Instruments/Supply